36
Views
0
CrossRef citations to date
0
Altmetric
Short Report

A case of Dapsone Induced Methemoglobinemia

ORCID Icon, , , &
Article: 22 | Received 01 Oct 2018, Accepted 11 Jun 2019, Published online: 28 Nov 2023

References

  • Wesley C. Understanding acquired methemoglobinemia. Nursing. 2014;44(2):67.
  • Raju Khanal Paras Karmacharya, Pathak Ranjan, Poudel Dilli Ram, Ghimire Sushil, Alweis Richard. Do all patients with acquired methemoglobinemia need treatment? A lesson learnt. Journal of Community Hospital Internal Medicine Perspect. 2015;5(5).
  • Shivinder Singh NS, Pandith S, Ramesh GS. Dapsone-induced methemoglobinemia: “saturation gap”—the key to diagnosis. J Anaesthesiol Clin Pharmacol. 2014;30(1):86–88.
  • Kane GC, et al. Benzocaine-induced methemoglobinemia based on the Mayo Clinic experience from 28 478 transesophageal echocardiograms: incidence, outcomes, and predisposing factors. Arch Intern Med. 2007;167(18):1977–1982.
  • Zuidema J, Hilbers-Modderman ES, Merkus FW. Clinical pharmacokinetics of dapsone. Clin Pharmacokinet. 1986;11(4):299–315.
  • El-Husseini Amr, Azarov Nick. Is threshold for treatment of methemoglobinemia the same for all? A case report and literature review. The American Journal of Emergency Medicine. 2010. 28(6):748.e5-748.e10.
  • Abdul Rehman SKAS, Khan FM. Methemoglobinemia. Journal of Postgraduate Medical Institute. 1990;4(1):174–177.
  • Skold A, Cosco DL, Klein R. Methemoglobinemia: pathogenesis, diagnosis, and management. South Med J. 2011;104(11):757–761.
  • Kumar, M.D. -B.E.D.A.L.C.D.C.S.M. Methemoglobinemia Workup. Medscape 2017 Nov 14, 2017.